Sector Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:02 2026-09-03 pm EDT
|
5-day change | 1st Jan Change | ||
| 293.35 USD | +0.54% |
|
-0.59% | +47.06% |
| Aug. 20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| Aug. 20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.54% | -0.59% | +26.17% | +67.83% | +47.06% | +81.92% | +39.94% | -34.67% | +247.49% | 13.93B | |
| -0.24% | -0.99% | +3.52% | +17.24% | +8.22% | +3.26% | +18.17% | -25.10% | +210.40% | 50.14B | |
| +0.78% | -2.12% | +12.45% | +39.36% | +164.75% | +433.44% | +501.63% | +607.14% | - | 44.85B | |
| +2.95% | +3.87% | +15.57% | +50.37% | +20.50% | +47.83% | +21.08% | +2.41% | +252.94% | 43.43B | |
| +0.25% | -3.49% | +14.77% | +32.03% | +19.38% | +9.23% | +73.60% | +8.91% | +1,129.84% | 41.14B | |
| +0.43% | -3.26% | +0.21% | +4.55% | +8.54% | +14.75% | +49.08% | -20.98% | +144.05% | 32.92B | |
| +1.43% | +8.34% | +11.16% | +25.17% | - | - | - | - | - | 17.56B | |
| +0.06% | -4.15% | +2.82% | +33.17% | +5.65% | +25.36% | +116.96% | +206.01% | +1,832.87% | 16.55B | |
| +0.93% | +0.88% | +7.78% | +19.76% | +17.72% | +19.64% | +29.70% | -40.42% | +97.93% | 14.65B | |
| +2.34% | -3.17% | +0.01% | +18.93% | -10.23% | -8.02% | -37.73% | -37.39% | +112.06% | 12.33B | |
| +0.21% | +0.10% | +0.50% | +45.57% | +23.19% | +35.62% | -8.01% | -43.26% | +171.15% | 11.34B | |
| +4.39% | -5.58% | +47.39% | +30.31% | +9.50% | -17.46% | - | - | - | 11.18B | |
| +2.59% | -1.25% | -6.73% | +57.13% | -17.65% | +43.70% | +477.80% | +207.92% | +2,416.50% | 10.48B | |
| +2.26% | -2.67% | +16.85% | +78.87% | +51.25% | +35.95% | +46.06% | -46.19% | - | 10.55B | |
| -0.01% | +0.09% | +0.73% | +71.60% | +78.95% | +256.76% | +446.62% | - | - | 10.19B | |
| +1.34% | +2.72% | +101.00% | +199.01% | +192.27% | +106.37% | +97.50% | +2.25% | +1,400.00% | 9.99B | |
| -5.22% | -8.25% | +12.29% | -20.34% | -26.52% | +1.11% | +43.53% | +43.35% | +97.32% | 10.19B | |
| -1.14% | -6.59% | +13.42% | +64.51% | +50.73% | +188.23% | +490.53% | +93.24% | - | 9.86B | |
| -0.66% | -5.89% | +15.37% | +37.61% | +20.50% | +690.28% | +1,408.07% | +12.75% | - | 9.98B | |
| +1.86% | -1.78% | +8.90% | +59.61% | +70.37% | +152.85% | +661.51% | +199.88% | +1,131.79% | 9.45B | |
| Average | +0.53% | -2.18% | +15.21% | +46.62% | +38.64% | +111.62% | +248.67% | +66.82% | +711.10% | 19.53B | |
| Weighted average by Cap. | +0.68% | -1.79% | +12.54% | +38.69% | +40.74% | +105.11% | +187.71% | +91.61% | +586.90% |
- Stock Market
- Stocks
- CRL Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
